Individual results may vary: Inequality-probability bounds for some health-outcome treatment effects

Journal of Health Economics - Tập 61 - Trang 151-162 - 2018
John Mullahy1,2,3
1University of Wisconsin, Madison, USA
2NUI Galway, Ireland
3National Bureau of Economic Research USA

Tài liệu tham khảo

Aakvik, 2005, Estimating treatment effects for discrete outcomes when responses to treatment vary: an application to Norwegian vocational rehabilitation programs, J. Econom., 125, 15, 10.1016/j.jeconom.2004.04.002 Abadie, 2002, Bootstrap tests for distributional treatment effects in instrumental variable models, JASA, 97, 284, 10.1198/016214502753479419 Abbring, 2007, Econometric evaluation of social programs, part III: distributional treatment effects, dynamic treatment effects, dynamic discrete choice, and General equilibrium policy evaluation, Vol. 6B Abrevaya, 2000, testing for a treatment effect in a heterogeneous population: a modified sign-test statistic and a leapfrog statistic, J. Appl. Stat., 27, 679, 10.1080/02664760050081852 Adams, 2013 Allison, 2004, Measuring health inequality using qualitative data, J. Health Econ., 23, 505, 10.1016/j.jhealeco.2003.10.006 Andrews, 1997, A conditional kolmogorov test, Econometrica, 65, 1097, 10.2307/2171880 Angrist, 2004, Treatment effect heterogeneity in theory and practice, Econ. J., 114, C52, 10.1111/j.0013-0133.2003.00195.x Athey, 2006, Identification and inference in nonlinear difference-in-differences models, Econometrica, 74, 431, 10.1111/j.1468-0262.2006.00668.x Basu, 2016 Basu, 2007, Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients, Health Econ., 16, 1133, 10.1002/hec.1291 Bitler, 2006, What mean impacts miss: distributional effects of welfare reform experiments, Am. Econ. Rev., 96, 988, 10.1257/aer.96.4.988 Boole, 1854 Borah, 2011, Assessing the impact of high deductible health plans on health-care utilization and cost: a changes-in-changes approach, Health Econ., 20, 1025, 10.1002/hec.1757 Borghaei, 2015, Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer, NEJM, 373, 1627, 10.1056/NEJMoa1507643 Cameron, 2004, Modelling the differences in counted outcomes using bivariate copula models with application to mismeasured counts, Econom. J., 7, 566, 10.1111/j.1368-423X.2004.00144.x Carneiro, 2001, Removing the veil of ignorance in assessing the distributional impacts of social policies, Swedish Econ. Policy Rev., 8, 273 Castagnoli, 1984, Some remarks on stochastic dominance, Revista di Matematica per le Scienze Economiche e Sociali, 7, 15 Chan, 2006, Learning, private information, and the economic evaluation of randomized experiments, J. Polit. Econ., 114, 997, 10.1086/508239 Coate, 2000, An efficiency approach to the evaluation of policy changes, Econ. J., 110, 437, 10.1111/1468-0297.00532 Darling, 1957, The kolmogorov-smirnov, cramér-von mises tests, Ann. Math. Stat., 28, 823, 10.1214/aoms/1177706788 Denuit, 2002, Measuring the impact of dependence between claims occurrences, Insur. Math. Econ., 30, 1, 10.1016/S0167-6687(01)00088-9 Fan, 2010, Sharp bounds on the distribution of treatment effects and their statistical inference, Econ. Theory, 26, 931, 10.1017/S0266466609990168 Fan, 2012, Confidence intervals for the quantile of treatment effects in randomized experiments, J. Econom., 167, 330, 10.1016/j.jeconom.2011.09.019 Fan, 2014, Identifying treatment effects under data combination, Econometrica, 82, 811, 10.3982/ECTA10601 Fan, 2017, Partial identification of functionals of the joint distribution of’ potential outcomes, J. Econom., 197, 42, 10.1016/j.jeconom.2016.10.005 Firpo, 2008 Frandsen, 2018 Gastwirth, 1975, Statistical measures of earnings differentials, Am. Stat., 29, 32 Gerber, 2004, Beyond the median: voter preferences, district heterogeneity, and political representation, J. Polit. Econ., 112, 1364, 10.1086/424737 Hansen, 2017 Hauck, 2000, Generalized treatment effects for clinical trials, Stat. Med., 19, 887, 10.1002/(SICI)1097-0258(20000415)19:7<887::AID-SIM388>3.0.CO;2-L Heckman, 2001, Accounting for heterogeneity, diversity and general equilibrium in evaluating social programmes, Econ. J., 111, F654, 10.1111/1468-0297.00667 Heckman, 1997, Making the most out of programme evaluations and social experiments: accounting for heterogeneity in programme impacts, Rev. Econ. Stud., 64, 487, 10.2307/2971729 Horwitz, 1996, Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation, J. Clin. Epidemiol., 49, 395, 10.1016/0895-4356(95)00058-5 Huang, 2016, Inequality in treatment benefits: can we determine if a new treatment benefits the many or the few?, Biostatistics, 10.1093/biostatistics/kxw049 Imbens, 2004, Confidence intervals for partially identified parameters, Econometrica, 72, 1845, 10.1111/j.1468-0262.2004.00555.x Imbens, 2009, Recent developments in the econometrics of program evaluation, J. Econ. Lit., 47, 5, 10.1257/jel.47.1.5 Jacob, 2005, A median voter model of health insurance with Ex post moral hazard, J. Health Econ., 24, 407, 10.1016/j.jhealeco.2004.01.004 Koenker, 2001, Quantile regression for duration data: a reappraisal of the Pennsylvania reemployment bonus experiments, Empir. Econ., 26, 199, 10.1007/s001810000057 Kravitz, 2004, Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages, Milbank Q., 82, 661, 10.1111/j.0887-378X.2004.00327.x Langley, 2014, Secukinumab in plaque psoriasis—results of two phase 3 trials, NEJM, 371, 326, 10.1056/NEJMoa1314258 Lee, 2000, Median treatment effects in randomized trials, JRSS-B, 62, 595, 10.1111/1467-9868.00253 Lee, 2001, Proportional treatment effects for count response panel data: effects of binary exercise on health care demand, Health Econ., 10, 411, 10.1002/hec.626 Lee, 2016, Extended-release naltrexone to prevent opioid relapse in criminal justice offenders, NEJM, 374, 1232, 10.1056/NEJMoa1505409 Lynn, 2015, Value-based payments require valuing what matters to patients, JAMA, 314, 1445, 10.1001/jama.2015.8909 Makarov, 1982, Estimates for the distribution function of a sum of two random variables when the marginal distributions are fixed, Theory Prob. Appl., 26, 803, 10.1137/1126086 Mann, 1947, On a test of whether one of two random variables is stochastically larger than the other, Ann. Math. Stat., 18, 50, 10.1214/aoms/1177730491 Manski, 1988 Manski, 1996, Learning about treatment effects from experiments with random assignment of treatments, J. Hum. Resour., 31, 709, 10.2307/146144 Manski, 1997, Monotone treatment effect, Econometrica, 65, 1311, 10.2307/2171738 Manski, 2007 Mullahy, 2005, Individual results May vary, Barcelona (May 2005), Working Paper, Presented at the Conference on the Economics of Addiction and Health Inequality Nissen, 2016, Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis, NEJM, 375, 2519, 10.1056/NEJMoa1611593 Pauly, 1989, Positive political economy of medicare, past and future Rüschendorf, 2004, Comparison of multivariate risks and positive dependence, J. Appl. Probab., 41, 391, 10.1239/jap/1082999074 Scharfstein, 2004, On the construction of bounds in prospective studies with missing ordinal outcomes: application to the good behavior game trial, Biometrics, 60, 154, 10.1111/j.0006-341X.2004.00158.x Stinnett, 1998, Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis, Med. Decis. Making, 18, S68, 10.1177/0272989X98018002S09 Tamer, 2010, Partial identification in econometrics, Annu. Rev. Econom., 2, 167, 10.1146/annurev.economics.050708.143401 U.S. Food and Drug Administration, 2015 Volpp, 2009, A randomized, controlled trial of financial incentives for smoking cessation, NEJM, 360, 699, 10.1056/NEJMsa0806819 Willan, 2001, On the probability of cost-effectiveness using data from randomized clinical trials, BMC Med. Res. Method, 1, 8, 10.1186/1471-2288-1-8 Williamson, 1990, Probabilistic arithmetic. I. Numerical methods for calculating convolutions and dependency bounds, Int. J. Approximate Reasoning, 4, 89, 10.1016/0888-613X(90)90022-T Willke, 2012, From concepts, theory, and evidence of heterogeneity of treatment effects to methodological approaches: a primer, BMC Med. Res. Method, 12, 185, 10.1186/1471-2288-12-185